LNTH News and Press, Lantheus Holdings Inc. From 11/18/22

What's better than a stock that's a big winner? A stock that's a big winner that should be able to keep on winning in the future. There are more in this category than you might think. The following three stocks are absolutely crushing the market so far this year. And Wall Street thinks ...

Point Biopharma Global's ( NASDAQ: PNT ) stock fell ~35% on Monday after the company said it was selling licensing rights to radiopharmaceutical cancer drug candidates PNT2002 and PNT2003 to Lantheus ( NASDAQ: LNTH ). Upon completion, Lantheus ...

Collaboration pairs POINT’s expertise in next generation radioligand development and manufacturing with Lantheus’ commercial leadership in PSMA PET and radiopharmaceuticals Expands Lantheus’ portfolio with license of exclusive worldwide rights, excluding cer...

NORTH BILLERICA, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc . (“the Company”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find,...

Lantheus Holdings, Inc. (LNTH) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Mark Kinarney - VP, IR Mary Heino - President and CEO Paul Blanchfield – COO Robert Marshall - CFO and Treasurer Conference Call Part...

Lantheus Holdings ( NASDAQ: LNTH ) dropped ~8% in the morning hours Thursday to reach the lowest level since July, even after the diagnostic compound maker announced better-than-expected Q3 2022 financials and set its outlook ahead of the consensus. Lantheus ( LNTH...

Lantheus press release ( NASDAQ: LNTH ): Q3 Non-GAAP EPS of $0.99 beats by $0.16 . Revenue of $239.29M (+134.4% Y/Y) beats by $11.41M . Net cash provided by operating activities was $93.6 million for the third quarter 2022. Free cash flow was $87.5 million in t...

Worldwide revenue of $239.3 million for the third quarter 2022, representing an increase of 134.4% from the prior year period GAAP net income of $61.2 million for the third quarter 2022, compared to GAAP net loss of $13.4 million in the prior year period GAAP fully dilut...

Lantheus ( NASDAQ: LNTH ) is scheduled to announce Q3 earnings results on Thursday, November 3rd, before market open. The consensus EPS Estimate is $0.83 (+1137.5% Y/Y) and the consensus Revenue Estimate is $227.88M (+123.3% Y/Y). Over the last 2 years, LNTH has beat...

NORTH BILLERICA, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 3, 2022, to discuss its financial and operating results fo...